Auckland Regional Public Health Service, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, New Zealand.
Auckland Regional Public Health Service, Health New Zealand - Te Whatu Ora Te Toka Tumai Auckland, New Zealand.
Vaccine. 2024 Oct 3;42(23):126257. doi: 10.1016/j.vaccine.2024.126257. Epub 2024 Aug 27.
Isolation of cases and quarantining of non-immune contacts are the mainstay of measles outbreak management in elimination settings. Serology testing of exposed contacts may not be feasible in large outbreaks; therefore, vaccination history is used as a proxy for determining immunity to measles and thus prevention of onward virus transmission. This study sought to investigate the risk of measles virus transmission from individuals with a history of one or two doses of measles-containing vaccine (MCV).
Retrospective analysis of data from measles cases reported to Auckland Regional Public Health Service during the 2019 Auckland region measles outbreak. Vaccination history was verified using patient records and the New Zealand National Immunisation Register. Onward transmission was determined through case interviews and assessment of exposed contacts.
1451 measles cases were assessed as eligible for vaccination at the time of measles outbreak. Of these, 1015 (70.0%) were unvaccinated, 220 (15.2%) had unknown vaccination status, 139 (9.6%) had received only one dose of MCV and 77 (5.3%) had received two doses of the vaccine. Compared to unvaccinated cases, the odds of onward transmission were lower among those with one dose only (OR 0.41, 95% CI: 0.20-0.75) or two doses of MCV (OR 0.44, 95% CI: 0.17-0.95). Median time since vaccination was longer among those with onward transmission compared to those without onward transmission for one and two doses of the vaccine, suggesting a potential effect of waning immunity among this cohort.
These findings support the hypothesis that measles cases with a history of prior vaccination are less likely to transmit the virus to others compared to unvaccinated cases. Such information can be used to support decisions around quarantine requirements for vaccinated contacts in future measles outbreaks.
在消除麻疹的环境中,隔离病例和对无免疫力的接触者进行检疫是麻疹暴发管理的主要措施。在大规模暴发时,对暴露接触者进行血清学检测可能不可行;因此,疫苗接种史被用作确定麻疹免疫力并防止病毒继续传播的替代指标。本研究旨在调查有一次或两次含麻疹疫苗(MCV)接种史的个体将麻疹病毒传播给他人的风险。
对 2019 年奥克兰地区麻疹暴发期间向奥克兰地区公共卫生局报告的麻疹病例进行回顾性数据分析。通过患者记录和新西兰国家免疫登记册核实疫苗接种史。通过病例访谈和对暴露接触者的评估确定了继续传播情况。
在麻疹暴发时,评估了 1451 例麻疹病例有接种疫苗的资格。其中,1015 例(70.0%)未接种疫苗,220 例(15.2%)疫苗接种情况未知,139 例(9.6%)仅接种过一剂 MCV,77 例(5.3%)接种过两剂 MCV。与未接种疫苗的病例相比,仅接种一剂(OR 0.41,95%CI:0.20-0.75)或两剂 MCV(OR 0.44,95%CI:0.17-0.95)的病例继续传播的可能性较低。与未继续传播的病例相比,继续传播的病例中,一剂和两剂 MCV 的疫苗接种后时间中位数更长,这表明该队列中免疫效力可能随时间减弱。
这些发现支持了以下假设,即与未接种疫苗的病例相比,有既往接种史的麻疹病例将病毒传播给他人的可能性较小。这些信息可用于支持未来麻疹暴发时对已接种疫苗的接触者进行检疫要求的决策。